ABOUT US

About Northway Biotech US

Northway Biotech is a flexible biologics CDMO with a facility in a Greater Boston area, a world-leading hub in the field of life sciences research and drug development.

Our global teams based in the US and Europe are exceptionally well-versed in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and aseptic fill-finish.

Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment and analytical support, as well as a cGMP manufacturing suite with both single-use and stainless steel systems for upstream and downstream process development, formulation and fill-finish of microbial and mammalian cell culture-based products.

We are deeply invested in providing high quality, world-class CDMO services and long-term partnerships based on our blend of experience and openly collaborative project teams.

Management & Operations

Prof. Vladas Algirdas Bumelis

CEO, Executive Chairman of the Board & Advisory Board

Prof. Vladas Bumelis is the Founder of Northway Biotech and currently serves as Chairman of the company’s Board and Advisory Board. With extensive experience in the pharmaceutical and biotech industries, he previously held key positions such as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for Biofa and Biotechna, and served as Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania.

Prof. Bumelis is the author of 157 scientific publications and 32 inventions. Notable accolades include being named CEO of the year in Lithuania in 2012 and receiving the Lithuanian Science Prize in 2004 for his pioneering work in the development and production of recombinant proteins. In 2020, he was honored with the Officer's Cross Award of the Order "For Merit to Lithuania." Prof. Bumelis holds a Ph.D. and MSc in Chemistry, along with a Ph.D. in Biotechnology from Vilnius University.

Vladas has a Ph.D. in chemistry, as well as a Ph.D. in biotechnology from Vilnius University, Lithuania.

Ralph Spradley

Interim Site Head/ Head of Quality Assurance

With a decade of experience in Quality Assurance and pharmaceutical production, Ralph Spradley is an expert in FDA, cGMP, and GDP standards. His skill set includes conducting audits, developing training programs, overseeing on-the-floor activities, and administering eQMS. Ralph holds an MBA in Business Administration and Continuous Improvement, along with a BS in Psychology from York College of Pennsylvania. His prior roles include positions at STC Biologics Inc., Pharmaceutics International Inc., Lonza, Thermo Fisher Scientific, and McNeil Consumer Pharmaceuticals.

Ray Li

Interim Head of Upstream and Downstream Process Development

With 14 years of expertise in Upstream process development within biopharmaceutical production, Ray Li brings extensive knowledge in high throughput design of experiment, small-scale and parallel bioreactors, microbial fermentation, and mammalian cell culture. His skill set extends to technology transfer, cGMP manufacturing floor support, and employee training. Ray holds an MBA in Business Administration from the Isenberg School of Management, UMass Amherst, and a BS in Biology from Rensselaer Polytechnic Institute. Prior to his current role, Ray was working at Elevian Inc., Allena Pharmaceuticals, Boston Institute of Biotechnology, LLC, Amgen, and Lonza.

Michael Carlson

Head of Analytical Development / Quality Control

Michael Canon has over 30 years of experience in GMP-qualified assay development, lab management, and equipment qualification. Previously, he served as Director of AD/QC at a CDMO specializing in generic OTC, Rx, and medical device production. Michael holds a master’s degree in chemistry from the University of Massachusetts at Lowell.

Business Development Team

Detra Glinatsis

Vice President, Business Development

Detra Glinatsis has over 20 years of sales experience in the pharmaceutical, biotech and contract manufacturing industries. Her passion, creativity, and commitment to satisfy customer needs have led to a remarkable reputation in the industry. Prior to joining Northway, Detra has served as a Senior Director of Business Development at AGC Biologics, Rentschler BioPharma, and Gallus Biopharmaceuticals. In these roles, her efforts spearheading business development and client relationship management generated significant new business growth. Detra has also served in business and commercial development positions at Avecia Biologics, InVentiv Health, and Sartorius. Detra holds a bachelor’s in biology from the University of Akron, USA.